CYBQF

CYBERDYNE Unveils Innovative Cardiac Monitoring Device

CYBERDYNE (JP:7779) has released an update.

Pick the best stocks and maximize your portfolio:

CYBERDYNE Inc. has received certification for its new Medical Vital Sensor ‘Cyvis M100’ in Japan, which will soon be covered by public health insurance. This innovative device promises to enhance cardiac monitoring with its ability to record heart activity for up to 10 days, aiding in the early detection and treatment of serious conditions like atrial fibrillation. The company plans to expand the Cyvis series to include additional health metrics, contributing to comprehensive healthcare solutions.

For further insights into JP:7779 stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.